Revenue

The burger chain posted robust revenue and a massive jump in annual net income, outperforming rivals and detailing plans for major global expansion.

With promising data for its oral STAT6 degrader and a cash runway into 2029, Kymera Therapeutics is poised to disrupt the injectable-dominated market.

Former USAA CEO Wayne Peacock joins Cotality's board, signaling a strategic push to lead the AI-driven property data and insurance analytics market.

Consolidated Lithium Metals aims to raise $17.07 million to advance its Quebec rare earth and lithium projects, capitalizing on key investor tax incentives.

Kairos Pharma aims to reshape lung cancer treatment by acquiring two AI-designed drugs, targeting a key resistance mechanism in a multi-billion dollar market.

After a massive divestiture, Vistance Networks reports soaring growth, zero debt, and plans a huge special cash distribution to its shareholders.

With a key FDA decision looming and pivotal data on a second therapy imminent, Viridian is poised to reshape the multi-billion dollar Thyroid Eye Disease market.

Facing slow auto OEM cycles, Arbe Robotics names a new CEO and targets defense, robotaxis, and China to accelerate revenue from its high-res radar tech.

After a strong 2025, Viatris unveils a plan for $650M in savings, a 10% workforce cut, and a focus on six new drugs to fuel future innovation.

In a market dominated by wood, one developer is betting on steel. Discover how cold-formed steel is creating stronger, safer, and more resilient homes.

The energy giant unveils a massive capital plan to boost regulated assets, even as a $471M write-down on renewables reveals significant grid challenges.

With record SUBLOCADE revenue and a new U.S. home, Indivior launches a $400M buyback, signaling a new era in its fight against the opioid crisis.

With soaring sales for its rare obesity drug IMCIVREE, Rhythm Pharmaceuticals faces a critical March FDA decision that could unlock a massive new market.

New analyses of Upstream Bio's verekitug aim to prove its true effectiveness for nasal polyps, setting the stage for a competitive showdown.

Middleby names veteran leaders for its high-growth Food Processing unit, setting the stage for a 2026 public debut in a booming automation market.

Kolibri Global Energy Inc. just released its first sustainability report. Is it a genuine shift or a strategic play in a world demanding greener energy?

Semiconductor firm Aeluma will meet investors at the ROTH conference, betting its unique, scalable chip technology is the key to powering the future of AI and AR/VR.

A new collaboration is betting on tiny natural particles to deliver a gene-editing cure for a devastating neurological disorder, bypassing a key medical hurdle.

The energy giant is using a complex financial tool to fund major projects. We break down what it means for investors and the future of the power grid.

Eos Energy reports record revenue and a fortified balance sheet, resolving 'going concern' doubts, but sets 2026 guidance below analyst expectations.